This study presents a simple approach for the noninvasive assignment of glial brain tumors according to malignancy by single-voxel proteon magnetic resonance spectroscopy at short echo times (TE≦50 milliseconds). Based on peak area ratios, a five-dimensional data set was obtained for each investigated subject. This vector was then projected along metabolic coordinates in a two-dimensional metabolic space. These coordinates had been determined in a previous study (Hagberg G et al., 1995,Magn Reson Med 34: 242–252). Tumor assignment was done without any knowledge of histology by comparing the location of the new cases to the features of the previous study. All 11 investigated glioblastomas multiforme, as well as 4 of 5 astrocytomas grade II, ...
Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic and is the neuroimaging method of...
Background: MR spectroscopic imaging (MRSI), or chemical shift imaging (CSI), is a newer noninvasive...
Despite ever more advanced characterization, the family of malignant central nervous system diseases...
This study presents a simple approach for the noninvasive assignment of glial brain tumors according...
Seventeen patients with presumed glial brain tumors were examined with proton chemical shift imaging...
BACKGROUND AND PURPOSE: Our purpose was to develop a classification scheme and method of presentatio...
Patients with intracranial tumors (gliomas) were examined by means of localized water-suppressed 1H ...
Hydrogen-1 magnetic resonance spectroscopy (1H-MRS) allows noninvasive in vivo quantification of met...
Abstract — Hydrogen-1 magnetic resonance spectroscopy ( 1H-MRS) allows noninvasive in vivo quantific...
A recently developed method for image-selected localized hydrogen-1 magnetic resonance (MR) spectros...
Abstract. In vivomagnetic resonance spectroscopy (MRS) studies of glial brain tu-mours reported that...
ABSTRACT: High-resolution proton magnetic resonance spectroscopy was performed on tissue specimens f...
Gliomas account for about 40% of total primitive brain tumors, and discrimination between high and l...
1H image-guided 31P MR spectra of normal human brain and of intracranial tumors have been analyzed q...
Proton magnetic resonance spectroscopic imaging (1H-MRSI) and positron emission tomography with the ...
Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic and is the neuroimaging method of...
Background: MR spectroscopic imaging (MRSI), or chemical shift imaging (CSI), is a newer noninvasive...
Despite ever more advanced characterization, the family of malignant central nervous system diseases...
This study presents a simple approach for the noninvasive assignment of glial brain tumors according...
Seventeen patients with presumed glial brain tumors were examined with proton chemical shift imaging...
BACKGROUND AND PURPOSE: Our purpose was to develop a classification scheme and method of presentatio...
Patients with intracranial tumors (gliomas) were examined by means of localized water-suppressed 1H ...
Hydrogen-1 magnetic resonance spectroscopy (1H-MRS) allows noninvasive in vivo quantification of met...
Abstract — Hydrogen-1 magnetic resonance spectroscopy ( 1H-MRS) allows noninvasive in vivo quantific...
A recently developed method for image-selected localized hydrogen-1 magnetic resonance (MR) spectros...
Abstract. In vivomagnetic resonance spectroscopy (MRS) studies of glial brain tu-mours reported that...
ABSTRACT: High-resolution proton magnetic resonance spectroscopy was performed on tissue specimens f...
Gliomas account for about 40% of total primitive brain tumors, and discrimination between high and l...
1H image-guided 31P MR spectra of normal human brain and of intracranial tumors have been analyzed q...
Proton magnetic resonance spectroscopic imaging (1H-MRSI) and positron emission tomography with the ...
Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic and is the neuroimaging method of...
Background: MR spectroscopic imaging (MRSI), or chemical shift imaging (CSI), is a newer noninvasive...
Despite ever more advanced characterization, the family of malignant central nervous system diseases...